Literature DB >> 6177893

Murine tumor necrosis-inducing factor: purification and effects on myelomonocytic leukemia cells.

S Green, A Dobrjansky, M A Chiasson.   

Abstract

The tumor necrosis-inducing factor (TNF) found in sera of Corynebacterium parvum-treated, endotoxin-stressed BALB/C and outbred albino CD-1 mice has been purified to a single band of protein by polyacrylamide gel electrophoresis after identification and removal of contaminating albumin and transferrin. This purified TNF has a molecular weight of 140,000, is glycoprotein in nature, and migrates on free electrophoresis as an alpha 2-globulin. TNF activity was continuously monitored during purification by bioassay in vitro (tumor cell lysis) and was confirmed by demonstration of induction of tumor necrosis in vivo. A single target tumor cell line, murine myelomonocytic leukemia (WEHI/3), was used in both assays. In the in vivo assay, controls were heat-inactivated samples of TNF. As additional controls, a line of TNF-resistant WEHI/3 cells was used in the in vitro assay. Results from in vivo radiolabeling of TNF-sensitive and TNF-resistant cells indicated a difference between their cytoplasmic peptide profiles. Optimal TNF production was not altered in C. parvum-endotoxin-treated mice by treatment with silica, a substance that is specifically toxic for macrophages. Exposure of mice to 650 rad whole-body radiation, which is not markedly damaging to macrophage elements in the reticuloendothelial system, completely abrogated the ability of the mice to produce TNF after C. parvum-endotoxin treatment. These findings suggest that in the sera of C. parvum-endotoxin-treated mice the protein that induces necrosis in tumors may not be of macrophage origin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177893

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

1.  Macrophage functions in Biozzi mice.

Authors:  H M Dockrell; J Taverne; R Lelchuk; P Depledge; I N Brown; J H Playfair
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

Review 2.  Tumor necrosis factor and cancer, buddies or foes?

Authors:  Xia Wang; Yong Lin
Journal:  Acta Pharmacol Sin       Date:  2008-11       Impact factor: 6.150

3.  Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor.

Authors:  K Haranaka; E A Carswell; B D Williamson; J S Prendergast; N Satomi; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Endotoxin-mediated necrosis and regression of established tumours in the mouse. A correlative study of quantitative changes in blood flow and ultrastructural morphology.

Authors:  G G MacPherson; R J North
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice.

Authors:  N Bloksma; F M Hofhuis
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

6.  Cytotoxic factor production by Kupffer cells elicited with Lactobacillus casei and Corynebacterium parvum.

Authors:  S Hashimoto; Y Seyama; T Yokokura; M Mutai
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

7.  A trial sequential meta-analysis of TNF-α -308G>A (rs800629) gene polymorphism and susceptibility to colorectal cancer.

Authors:  Raju K Mandal; Munawwar Ali Khan; Arif Hussain; Naseem Akhter; Arshad Jawed; Sajad A Dar; Mohd Wahid; Aditya K Panda; Mohtashim Lohani; Bhartendu N Mishra; Shafiul Haque
Journal:  Biosci Rep       Date:  2019-01-15       Impact factor: 3.840

8.  High TNF-α and/or p38MAPK expression predicts a favourable prognosis in patients with T1N0M0 hepatocellular carcinoma: An immunohistochemical study.

Authors:  Mao Zhang; Jie Hu; Haoran Li; Shun Zhang; Weiyu Hu; Liqun Wu; Bing Han
Journal:  Oncol Lett       Date:  2019-03-27       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.